Advanced search
Publication Cover
Infectious Diseases Volume 47, 2015 - Issue 1
Submit an article Journal homepage
400
Views
26
CrossRef citations to date
0
Altmetric
SHORT COMMUNICATION

Oral human papillomavirus (HPV) prevalence in youth and cervical HPV prevalence in women attending a youth clinic in Sweden, a follow up-study 2013–2014 after gradual introduction of public HPV vaccination

Nathalie Grün From the Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected] [email protected]
,
Andreas Ährlund-Richter From the Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
,
Joar Franzén From the Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
,
Leila Mirzaie From the Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
,
Lena MarionsDepartment of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden
,
Torbjörn Ramqvist From the Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
&
Tina Dalianis From the Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected] [email protected]
 show all
Pages 57-61 | Received 15 Jul 2014, Accepted 03 Sep 2014, Published online: 07 Nov 2014

References

  • Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–17.
  • Ramqvist T, Dalianis T. Oropharyngeal cancer epidemic and human papillomavirus. Emerg Infect Dis 2010;16:1671–77.
  • Ramqvist T, Du J, Lunden M, Ährlund-Richter S, Ferreira J, Marions L, et al. Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15– 23-year-old women attending a youth health clinic in Stockholm, Sweden. Scand J Infect Dis 2011;43:115–21.
  • Du J, Nordfors C, Ährlund-Richter A, Sobkowiak M, Romanitan M, Nasman A, et al. Prevalence of oral human papillomavirus infection among youth, Sweden. Emerg Infect Dis 2012;18:1468–71.
  • Leval A, Herweijer E, Arnheim-Dahlström L, Walum H, Frans E, Sparén P, et al. Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability. J Infect Dis 2012;206:860–6.
  • Kreimer AR, Bhatia RK, Messeguer AL, Gonzalez P, Herrero R, Giuliano AR. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis 2010;37:386–91.
  • Nordfors C, Grün N, Haeggblom L, Tertipis N, Sivars L, Mattebo M, et al. Oral human papillomavirus prevalence in high school students of one municipality in Sweden. Scand J Infect Dis 2013;45:878–81.
  • Mattebo M, Grün N, Rosenblad A, Larsson M, Häggström-Nordin E, Dalianis T, et al. Sexual experiences in relation to HPV vaccination status in female high school students in Sweden. Eur J Contracept Reprod Health Care 2014;19:86–92.
  • Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518–27.
  • IARC. Human papillomaviruses. In: IARC Monographs on the Evaluation of carcinogenic risk to humans, Volume 100B. A review of human carcinogens. Biological agents. WHO; 2011 pp 261–301.
  • Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, et al. CVT Vaccine Group. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One 2013;8:e68329.
  • Antonsson A, Cornford M, Perry S, Davis M, Dunne MP, Whiteman DC. Prevalence and risk factors for oral HPV infection in young Australians. PLoS One 2014; 9:e91761.
  • Cook RL, Thomson EL, Kelso NE, Friary J, Hosford J, Barkley P, et al. Sexual behaviours and other risk factors for oral human papillomavirus infections in young women. Sex Transm Dis 2014;41;486–92.
  • Baudu A, Prétet JL, Riethmuller D, Chotard M, Mougin C, Mercier M. Prevalence and risk factors of human papillomavirus infection types 16/18/45 in a cohort of French females aged 15–23 years. J Epidemiol Glob Health 2014;4:35–43.
  • Tabrizi SN1, Brotherton JM, Kaldor JM, Skinner SR, Cummins E, Liu B, et al. Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis 2012;206:1645–51.
  • Markowitz LE, Hariri S, Lin C, Dunne EF, Steinau M, McQuillan G, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010. J Infect Dis 2013;208:385–93.
  • Deleré Y, Remschmidt C, Leuschner J, Schuster M, Fesenfeld M, Schneider A, et al. Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling. BMC Infect Dis 2014;14:87.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.